Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality. - Wikidata - wikimedia - TriplyDB

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.

http://www.wikidata.org/entity/Q30504100

about

Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma Inherited susceptibility for aggressive prostate cancer Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.Circadian gene variants in cancer.Diversity of human clock genotypes and consequences.Prostate cancer in young men: an important clinical entity.Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.Circadian clock genes and risk of fatal prostate cancer.Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families Polymorphism in LEP and LEPR May Modify Leptin Levels and Represent Risk Factors for Thyroid Cancer.Associations between polymorphisms in the IL-4 and IL-4 receptor genes and urinary carcinomas: a meta-analysis.Profiling prostate cancer.Replication of a genetic variant for prostate cancer-specific mortality.Computational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer.Prostate cancer - a biomarker perspective.Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF).Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy.The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study.Circadian pathway genes in relation to glioma risk and outcome.Genetic polymorphisms in leptin, adiponectin and their receptors affect risk and aggressiveness of prostate cancer: evidence from a meta-analysis and pooled-review.Genetic variants within endothelial nitric oxide synthase gene and prostate cancer: a meta-analysis.Risk stratification in prostate cancer screening.Estimating Heritability of Prostate Cancer-Specific Survival Using Population-Based Registers.Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes.Overexpression of small GTPases directly correlates with expression of δ-catenin and their coexpression predicts a poor clinical outcome in nonsmall cell lung cancer.Genotyping of single nucleotide polymorphisms by melting curve analysis using thin film semi-transparent heaters integrated in a lab-on-foil system.Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.Dysregulation of metallothionein and circadian genes in human hepatocellular carcinoma.Immunogenetics of prostate cancer: a still unexplored field of study.ARVCF expression is significantly correlated with the malignant phenotype of non-small cell lung cancer.Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival.

P2860

Q26786149-96C7A3B2-1042-405A-8F69-1A136C745CC7 Q27001297-4B9A33D6-7A85-432F-8A66-48E13A3CC730 Q33845203-3CB0024A-889A-4558-864D-98D43C8B1F3B Q34127839-715E85F6-DDCE-4F21-BC95-A07F120D0F2C Q34214140-5BBC377E-9ABC-44B2-A788-7789A8CA8784 Q34314644-F54009FD-99E8-4B05-B379-6056D51CE47A Q34636364-042BB171-0378-40EC-BC1A-4CE13107E8B9 Q34810303-00B9ED8C-02C6-4925-A37B-4DF0954ACD4B Q35091272-963C4A36-D80B-46E9-9B53-33332B4EE959 Q35165239-75097160-B781-4049-8996-170343BE0EAC Q35173821-0822EF01-8602-4E03-A505-2D9D79246921 Q35641430-02C35D95-1D79-4D02-BEB3-9E06DEF06A8A Q35956401-20454BC2-7EA9-4ADE-8EA2-C52F4BF3995C Q35989733-C5163BF3-29C5-4CEB-B2D3-811474F2E094 Q35992814-F378C90C-C86E-4B76-B8F5-35C5980CA57F Q36100579-73DD4907-5B23-4C13-A1BA-5697D2C30C0E Q36463837-04AC9705-8BB7-4E27-B066-EDA360E29541 Q36471474-6B882CDA-F516-48D0-A9A5-F1852D040AF0 Q36477652-1A3A86C9-C94F-415D-8726-3C912EFC59AD Q36570819-8991C12A-DA0E-4ABF-90AB-3299685280F6 Q37593392-30F5A348-7603-4F25-87C4-A80E57B2E8F7 Q37626221-9356903E-4339-4245-AEA3-33847664E3BD Q37697117-4EFE292A-B0CB-45D1-87CD-FF5D858F9D99 Q37700582-31F2B230-3556-4A2A-B403-669E79ABAAD2 Q38068114-EBA032F3-A2B7-40DC-964F-CF48223E1F45 Q38402430-7DA23819-34B3-453B-AF97-85C786BE4A48 Q42152583-C1B0D542-D164-48CD-80F1-A5337B9A206D Q43492076-8A7AF193-48D5-4A34-9608-EDB206E04DDD Q43493090-673FB1D2-9DC0-4908-B388-F2C14A4DF875 Q47212637-1E4A17C5-1036-4CE5-AF03-F17CA9D1E6A2 Q48389021-BD5AEBF3-2D5E-458F-BF5B-9EAFFD77B9AA Q50082109-B52B4ACE-9B04-4BE2-AFE4-2DA7FAF69830 Q53615769-1E2309DA-937A-4899-AA1C-A6B4E5D9FEDC Q55693698-5232D68B-2F7F-4FCD-BF1D-E489292ED284

P2860

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.

http://www.wikidata.org/entity/Q30504100

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Genetic variants in the LEPR, ...... ate cancer-specific mortality.

@ast

Genetic variants in the LEPR, ...... ate cancer-specific mortality.

@en

type

label

Genetic variants in the LEPR, ...... ate cancer-specific mortality.

@ast

Genetic variants in the LEPR, ...... ate cancer-specific mortality.

@en

prefLabel

Genetic variants in the LEPR, ...... ate cancer-specific mortality.

@ast

Genetic variants in the LEPR, ...... ate cancer-specific mortality.

@en

P1433

Q30504100-AA0B8855-7F19-42F9-962C-4420D895B0AC

P1476

Q30504100-FCD5F878-F1AF-4530-A575-CFB7CEA8746B

P2093

Q30504100-204DFCC1-295E-4301-A809-2BEF84C82D49

Q30504100-31977111-CB4E-4FA4-9BA8-A222116FE6B0

Q30504100-4351CB1F-B191-45CA-BE84-761C2ED2B8FE

Q30504100-6B2BBE94-B3CF-4C38-BFFD-AE32ED406131

Q30504100-702BC61A-1798-4F0A-81A0-2D25D47D71C3

Q30504100-A0EC99E6-B6BC-41C3-A870-D59D05C43653

Q30504100-A81EA166-8421-4B77-BFA5-A30238435212

Q30504100-AC9E463E-BE3C-41E8-ADC9-E26BD476B213

Q30504100-C5BCBC80-9889-4F75-B3EE-96CAFA11E42D

Q30504100-F8021CD5-9B20-4D9D-9EC3-103CFC89C10C

P2860

Q30504100-08761684-5492-4307-8266-1D28981CAC66

Q30504100-0C58BC9F-1A73-4C41-A89F-DCC50309C0E1

Q30504100-17B951DD-9483-4CE1-9773-CF8E758A70E0

Q30504100-19C3F067-19C3-47E1-891E-38504C810ADB

Q30504100-1DB45A97-9B8B-4586-A299-483464110CD2

Q30504100-1EB80D0A-27EC-449D-9E03-3DA9655ECEE1

Q30504100-22F5CED3-2ED7-45CD-9942-C247BD7BCB5B

Q30504100-285716F2-A8AE-4C42-8F48-F8DE58F837AE

Q30504100-2D7D650C-CA9C-4F48-8B85-AC4E7C08D999

Q30504100-2DD60C48-8B36-47B2-B178-9C33481BE46E

P304

Q30504100-823E4881-75B7-482C-BA8C-87628788CAFF

P31

Q30504100-035882CB-9B57-4B6B-BC86-5DB67895CE89

P356

Q30504100-371AFBFC-5D11-42E1-AEA2-9D9437A2A2C0

P433

Q30504100-AAB88D97-E921-4B17-A014-32AF5A5489F7

P478

Q30504100-BA743C32-206C-44B5-9344-E703E6452556

P50

Q30504100-096CEAE4-E1E0-4B9E-838D-5CD2E7FDF63D

Q30504100-E537C27F-37BB-41E0-B946-593271472F7B

Q30504100-EC766973-2996-48A4-9F5D-F95A7CA7EE6D

Q30504100-F76BEC5B-1C0A-4BA3-B72A-26B17F705DAE

P577

Q30504100-754A05A2-364C-4863-A136-77277B2F2124

P5875

Q30504100-041AC235-A4FD-41B9-944C-1DAEC583DFF6

P698

Q30504100-77FACBB7-1E57-4537-9775-DD5B24A07E7C

P932

Q30504100-84FAF1B9-24C2-45FA-982C-4F24C75E7248

P356

1055-9965.EPI-11-0236

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Genetic variants in the LEPR, ...... ate cancer-specific mortality.

@en

P2093

Daniel W Lin

http://www.w3.org/2001/XMLSchema#string

Erika M Kwon

http://www.w3.org/2001/XMLSchema#string

Fredrik Wiklund

http://www.w3.org/2001/XMLSchema#string

Janet L Stanford

http://www.w3.org/2001/XMLSchema#string

Pär Stattin

http://www.w3.org/2001/XMLSchema#string

Rong Fu

http://www.w3.org/2001/XMLSchema#string

Siqun Lilly Zheng

http://www.w3.org/2001/XMLSchema#string

Suzanne Kolb

http://www.w3.org/2001/XMLSchema#string

William B Isaacs

http://www.w3.org/2001/XMLSchema#string

Ziding Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D pathway gene variants and prostate cancer prognosis

Coordination of circadian timing in mammals

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

Time zones: a comparative genetics of circadian clocks

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells

Multiple newly identified loci associated with prostate cancer susceptibility

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

Leptin regulates proinflammatory immune responses

Multiple loci identified in a genome-wide association study of prostate cancer

P304

1928-1936

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-11-0236

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Elaine Ostrander

Henrik Grönberg

Liesel FitzGerald

P577

2011-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51576255

http://www.w3.org/2001/XMLSchema#string

P698

21846818

http://www.w3.org/2001/XMLSchema#string

P932

3169727

http://www.w3.org/2001/XMLSchema#string